Bobbi Durst, APRN
Psychiatric/Mental Health · Pewaukee, WINPI 1407405566
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Supernus Pharmaceuticals, Inc. accounts for 74.0% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $17,697, more than ten times the $937 reported in 2021. Among psychiatric/mental health clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 468 payments — averaging $49.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$17K
- Teva Pharmaceuticals USA, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$720
- AbbVie$663
- Alkermes, Inc.$584
- Otsuka America Pharmaceutical, Inc.$394
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$13,40058%
- Travel & lodging$1,4536%
- Food & beverage$8,18935%
- Education$1581%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 153 | $17,169 |
| Teva Pharmaceuticals USA, Inc. | 48 | $1,271 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $720 |
| AbbVie | 50 | $663 |
| Alkermes, Inc. | 29 | $584 |
| Otsuka America Pharmaceutical, Inc. | 27 | $394 |
| Lundbeck LLC | 20 | $376 |
| Corium, LLC | 25 | $368 |
| Axsome Therapeutics, Inc. | 20 | $228 |
| Tris Pharma Inc | 6 | $217 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $156 |
| Vanda Pharmaceuticals Inc. | 5 | $150 |
| Johnson & Johnson | 9 | $150 |
| Indivior Inc. | 6 | $115 |
| Neurocrine Biosciences, Inc. | 6 | $112 |
| USWM, LLC | 5 | $101 |
| Ironshore Pharmaceuticals Inc. | 4 | $80 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
| Almatica Pharma LLC | 3 | $57 |
| Sage Therapeutics, LLC | 3 | $55 |
| Sunovion Pharmaceuticals Inc. | 4 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Adlon Therapeutics L.p. | 2 | $28 |
| Eisai Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Merck | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$15,008
- UZEDY$365
- CAPLYTA$231
- Dyanavel XR$125
- Quillivant$125
- Quillichew ER$125
- VRAYLAR$114
How this compares
$23,200 in reported general payments places this provider in the 95th percentile of 384 psychiatric/mental health providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 50 | $394,554 |
| Austedo XrDeutetrabenazine | 37 | $256,779 |
| VraylarCariprazine Hcl | 193 | $234,092 |
| CaplytaLumateperone Tosylate | 123 | $171,344 |
| NuedextaDextromethorphan Hbr/Quinidine | 91 | $121,443 |
| IngrezzaValbenazine Tosylate | 12 | $110,572 |
| AristadaAripiprazole Lauroxil | 14 | $44,922 |
| SecuadoAsenapine | 21 | $30,070 |
| BelsomraSuvorexant | 50 | $23,292 |
| AuvelityDextromethorphan Hbr/Bupropion | 19 | $19,888 |
| Aripiprazole | 226 | $19,346 |
| RexultiBrexpiprazole | 24 | $18,434 |
| TrintellixVortioxetine Hydrobromide | 26 | $10,364 |
| VyvanseLisdexamfetamine Dimesylate | 22 | $8,309 |
| Ziprasidone Hcl | 41 | $7,101 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $1,271 | $651,33387 claims |
| AbbVieVraylar | $663 | $234,092193 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $720 | $171,344123 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $112 | $110,57212 claims |
| Alkermes, Inc.Aristada | $584 | $44,92214 claims |
| MerckBelsomra | $13 | $23,29250 claims |
| Axsome Therapeutics, Inc.Auvelity | $228 | $19,88819 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $156 | $18,67248 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $394 | $18,43424 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $17,169 | $4,21113 claims |
| Almatica Pharma LLCSertraline Hcl | $57 | $1,156107 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 384 psychiatric/mental health providers in Wisconsin.
Other psychiatric/mental health in Pewaukee
- Carolyn DavidsonMilwaukee$46K
- Sherry AleksichMilwaukee$33K
- Ngozi ObioraMilwaukee$19K
- Glenda McConnellGreen Bay$14K
- Debra BenishekGreen Bay$12K
- Shalonda MylesBrown Deer$12K
- Victoria McGinleyMilwaukee$9K
- Janet BurnsBrookfield$9K
- Alyssa SkalitzkyKenosha$8K
- Allen RindfleischOak Creek$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.